Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Dec;35(12):3525-32.
doi: 10.1002/eji.200535225.

Genetic control of thymic development of CD4+CD25+FoxP3+ regulatory T lymphocytes

Affiliations
Comparative Study

Genetic control of thymic development of CD4+CD25+FoxP3+ regulatory T lymphocytes

Paola Romagnoli et al. Eur J Immunol. 2005 Dec.

Abstract

Among the several mechanisms known to be involved in the establishment and maintenance of immunological tolerance, the activity of CD4+CD25+ regulatory T lymphocytes has recently incited most interest because of its critical role in inhibition of autoimmunity and anti-tumor immunity. Surprisingly, very little is known about potential genetic modulation of intrathymic regulatory T lymphocyte development. We show that distinct proportions of CD4+CD25+FoxP3+ regulatory T cells are found in thymi of common laboratory mouse strains. We demonstrate that distinct levels of phenotypically identical regulatory T cells develop with similar kinetics in the mice studied. Our experimental data on congenic mouse strains indicate that differences are not caused by the distinct MHC haplotypes of the inbred mouse strains. Moreover, the responsible loci act in a thymocyte-intrinsic manner, confirming the latter conclusion. We have not found any correlation between thymic and peripheral levels of regulatory T cells, consistent with known homeostatic expansion and/or retraction of the peripheral regulatory T cell pool. Our data indicate that polymorphic genes modulate differentiation of regulatory T cells. Identification of responsible genes may reveal novel clinical targets and still elusive regulatory T cell-specific markers. Importantly, these genes may also modulate susceptibility to autoimmune disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Distinct proportions of CD25+ regulatory thymocytes in various inbred mouse strains
(A) Freshly isolated thymocytes were analyzed by 4-color flow cytometry for expression of CD4, CD8, CD25 and TCR. The histograms depict TCR and CD25 levels of cells electronically gated on CD4 and CD8 as indicated. (B) The percentage of CD25+ among CD4+CD8TCRhi thymocytes in several inbred strains of mice (n≥10 per strain) was calculated using gates indicated in A. Mean values (± SD) are shown. Statistical significance between B6 and other strains is indicated (***p<0.001, NS, not significant, Student’s t-test). (C) CD25+TCRhiCD4+CD8 (“Treg”)/CD4+CD8+ (“DP”)(upper panel) and CD25TCRhiCD4+CD8 (“Teff”)/CD4+CD8+ (“DP”) ratios (lower panel) were determined for B6, SJL, and DBA/2 mice. Depicted are mean values ± SD (n≥4)(**p<0.01, ***p<0.001, Student’s t-test). (D) Thymocytes from DBA/2, SJL and B6 mice were labeled with Abs specific for CD4, CD8, CD25 and either TCR, HSA, CD69, GITR, or Foxp3. CD4+CD8 cells were electronically gated and analyzed for expression of indicated surface markers. (E) Percentage of FoxP3 expressing thymocytes among CD4SP thymocytes in the indicated mouse-strains. Mean values (± SD) are shown (n=4). Statistical significance is indicated (***p<0.001, *p<0.05, Student’s t-test). (F) PBMC and thymocytes from different inbred strains were stained with anti-TCR, anti-CD4, anti-CD8 and anti-CD25 antibodies and analyzed by flow cytometry. The percentage of CD25+ cells among CD4+CD8TCRhi cells was calculated. Mean values (± SD) are shown.
Figure 2
Figure 2. Quantitative difference in differentiation of mature CD25+ regulatory thymocytes in B6 vs. SJL mice
BrdU was continuously administrated to mice in their drinking water. At indicated timepoints, thymocytes were analyzed by 4-color flow cytometry using anti-CD4, anti-CD8, anti- CD25 and anti-BrdU Abs. The percentage of BrdU+CD25+ among CD4+CD8 (“CD4SP”) cells was calculated. Each point represents one mouse. Statistical significance of the difference between the two mouse strains was calculated for each day using Student’s t-test (**p<0.01, ***p<0.001).
Figure 3
Figure 3. Genes modulating CD25+ regulatory T cell differentiation are located outside the MHC
Thymocytes from indicated mouse strains were stained with anti-CD4, anti-CD8, anti-CD25 and anti-TCR Abs and analyzed as described in the legend to figure 1. Mean values (± SD) are shown (n≥5). Statistical significance was calculated using Student’s t-test (**p<0.01, ***p<0.001).
Figure 4
Figure 4. Distinct proportions of CD25+ regulatory T cells are determined by a thymocyte-intrinsic mechanism
(A) Lethally irradiated B6D2F1 hosts were reconstituted with bone marrow cells from B6 (CD5.2) and DBA/2 (CD5.1) at a 1:1 ratio. Six weeks later, thymocytes were analyzed by 4- color flow cytometry for expression of CD4, CD8, CD25 and CD5.1, using indicated electronic gates. (B) Similar experiments were performed using B6SJLF1 recipients injected with B6 (CD45.2) and SJL (CD45.1) bone marrow cells. (C) Quantitative analysis of CD25+ thymocyte development in mixed chimeras. Bar graphs depict mean values (± SD), n≥5. Statistical significance was calculated using Student’s t-test (**p<0.01, ***p<0.001).

Similar articles

Cited by

References

    1. Stockinger B. T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv Immunol. 1999;71:229–265. - PubMed
    1. Waldmann H, Graca L, Cobbold S, Adams E, Tone M, Tone Y. Regulatory T cells and organ transplantation. Semin Immunol. 2004;16:119–126. - PubMed
    1. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562. - PubMed
    1. Piccirillo CA, Shevach EM. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol. 2004;16:81–88. - PubMed
    1. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184:387–396. - PMC - PubMed

Publication types

MeSH terms

Substances